Retatrutide treatment in streptozotocin-induced diabetic rats: renal inflammatory cytokines, HIF‑1α expression, and histopathological injury profile
Journal of Molecular Histology · 2026
DOI: 10.1007/s10735-026-11013-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Histology, 2026. Verfasst von Ulya Keskin und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Department of Medical Pharmacology, Kütahya Health Sciences University, Kütahya, Turkey. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Diabetes Mellitus, Experimental, Kidney, Cytokines. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Model validity and inflammatory signature : Streptozotocin-induced diabetes produced a robust early diabetic kidney injury model, evidenced by significantly increased IL-1β levels and marked cortical and medullary histopathological damage in the diabetic group compared with controls. Histopathological protection by Retatrutide was not statistically confirmed : RET did not produce statistically significant histopathological protection under family-wise-corrected post hoc testing; however, STZ+RET animals showed consistently lower cortical and medullary scores than STZ animals, corresponding to large standardised effects (Cliff's δ = 0.90 and 0.85, respectively) whose confidence intervals excluded negligible differences. Retatrutide modulates hypoxia-related molecular responses : HIF-1α gene expression was highest in untreated diabetic kidneys and was significantly lower in diabetic animals treated with Retatrutide (S vs. SR, p = 0.020) - the contrast in which diabetic status is held constant. Retatrutide alone did not alter HIF-1α relative to controls (R vs. C, δ = −0.28), indicating that the effect emerges under diabetic conditions rather than reflecting generalised suppression, and that it precedes clear structural recovery. Inflammatory cytokines show partial, power-limited signals : While IL-1β was significantly increased in the diabetic group, renal TNF-α in Retatrutide-treated diabetic animals was indistinguishable from that of controls (SR vs. C, g* = 0.03) despite a large standardised difference from untreated diabetic animals (S vs. SR, g* = 1.60), a contrast that did not reach significance under the conservative Games–Howell correction at the available sample sizes. This pattern is compatible with an anti-inflammatory trend that the present design was underpowered to confirm. Renal safety signal and translational implication : Retatrutide alone did not induce renal toxicity, as total cortical and medullary scores and subparameter scores in the Retatrutide-only group were comparable to controls, aligning with clinical data suggesting a favourable renal safety profile of incretin-based therapies and supporting further evaluation in chronic, T2DM-like models with longer treatment and functional readouts. This study investigated whether Retatrutide, a triple incretin agonist, attenuates early diabetes-associated renal injury in a streptozotocin-induced rat model, and whether any protective effect is mediated through modulation of inflammatory cytokines (IL-1β, TNF-α) and HIF-1α gene expression in kidney tissue. Male Sprague-Dawley rats were divided into four groups: control, STZ-induced diabetic, STZ plus Retatrutide, and Retatrutide alone. Diabetes was induced via a single intraperitoneal STZ injection; Retatrutide was administered subcutaneously for 21 days at a dose adapted from prior metabolic studies. Renal tissue underwent ELISA for interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α), quantitative real-time PCR for HIF-1α expression, and semi-quantitative histopathological scoring of cortical and medullary parameters including haemorrhage, tubular dilatation, inflammatory cell infiltration, tubular vacuolisation, interstitial fibrosis, and intraluminal debris. STZ-induced rats exhibited significantly elevated cortical and medullary histopathological scores and increased renal IL-1β levels relative to controls, confirming successful early injury induction. Retatrutide did not produce statistically significant histopathological protection, although STZ plus Retatrutide animals showed consistently lower damage scores than STZ-only animals, corresponding to large standardised effects (Cliff’s δ = 0.90 in the cortex and 0.85 in the medulla) that could not be confirmed under family-wise error correction. HIF-1α expression was highest in the untreated diabetic group and was significantly lower in Retatrutide-treated diabetic animals (S vs. SR, p = 0.020), whereas Retatrutide alone did not alter expression relative to controls. TNF-α did not differ significantly in any pairwise comparison; levels in Retatrutide-treated diabetic animals were nonetheless comparable to controls (g* = 0.03). Retatrutide selectively modulated HIF-1α transcriptional levels in the acute STZ model without statistically confirmed histopathological renoprotection, and without evidence of intrinsic renal toxicity. Because the acute STZ model reflects insulin-deficient rather than T2DM-like disease, the model itself is a critical limitation; chronic type 2 diabetes models, together with longer treatment durations and refined dosing regimens, are required to determine whether the observed early molecular effects translate into structural renal benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Department of Medical Pharmacology, Kütahya Health Sciences University, Kütahya, Turkey.
- School of Medicine, Kütahya Health Sciences University, Kütahya, Turkey.
- School of Medicine, Department of Biochemistry, Kütahya Health Sciences University, Kütahya, Turkey.
- School of Medicine, Department of Histology and Embryology, Kütahya Health Sciences University, Kütahya, Turkey.
- School of Medicine, Kütahya Health Sciences University, Kütahya, Turkey. melkankkara@hotmail.com.
Zitieren
APA
Keskin, U., Altın, E., Özatik, F. Y., Sezgin, A. K., Gündoğdu, A. Ç., Arı, N. S., & Kara, M. K. (2026). Retatrutide treatment in streptozotocin-induced diabetic rats: renal inflammatory cytokines, HIF‑1α expression, and histopathological injury profile. Journal of Molecular Histology. https://doi.org/10.1007/s10735-026-11013-9
Vancouver
Keskin U, Altın E, Özatik FY, Sezgin AK, Gündoğdu AÇ, Arı NS, et al. Retatrutide treatment in streptozotocin-induced diabetic rats: renal inflammatory cytokines, HIF‑1α expression, and histopathological injury profile. Journal of Molecular Histology. 2026. doi:10.1007/s10735-026-11013-9
BibTeX
@article{Keskin2026,
author = {Keskin, Ulya and Altın, Eslem and Özatik, Fikriye Yasemin and Sezgin, Ayşe Koçak and Gündoğdu, Ayşe Çakır and Arı, Neziha Senem and Kara, Melkan Kağan},
title = {Retatrutide treatment in streptozotocin-induced diabetic rats: renal inflammatory cytokines, HIF‑1α expression, and histopathological injury profile},
journal = {Journal of Molecular Histology},
year = {2026},
doi = {10.1007/s10735-026-11013-9}
}
EUVIMED